The Clinical Significance of Plasma Pentraxin 3 levels for Patients with Diastolic Heart Failure
Not Applicable
- Conditions
- Patients with heart failure
- Registration Number
- JPRN-UMIN000002170
- Lead Sponsor
- Graduate School of Medical Sciences, Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria include active systemic inflammatory diseases, chronic renal failure requiring hemodialysis, active hepatic diseases, collagen diseases, presence of malignant tumor or acute coronary syndrome within 3 months preceding admission.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The clinical significance of plasma PTX3 levels for patients with left ventricular diastolic dysfunction
- Secondary Outcome Measures
Name Time Method cardiovascular events, which were a composite of CV death, non-fatal myocardial infarction or ischemic stroke, unstable angina, hospitalization for HF, or coronary revascularization.